These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 20936253)

  • 21. Combination therapy with glucagon-like peptide-1 and gastrin induces beta-cell neogenesis from pancreatic duct cells in human islets transplanted in immunodeficient diabetic mice.
    Suarez-Pinzon WL; Lakey JR; Rabinovitch A
    Cell Transplant; 2008; 17(6):631-40. PubMed ID: 18819251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
    Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
    Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A nanobody-based nuclear imaging tracer targeting dipeptidyl peptidase 6 to determine the mass of human beta cell grafts in mice.
    Demine S; Garcia Ribeiro R; Thevenet J; Marselli L; Marchetti P; Pattou F; Kerr-Conte J; Devoogdt N; Eizirik DL
    Diabetologia; 2020 Apr; 63(4):825-836. PubMed ID: 31873789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenoviral overproduction of interleukin-1 receptor antagonist increases beta cell replication and mass in syngeneically transplanted islets, and improves metabolic outcome.
    Téllez N; Montolio M; Estil-les E; Escoriza J; Soler J; Montanya E
    Diabetologia; 2007 Mar; 50(3):602-11. PubMed ID: 17221214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of exendin-4 treatment on graft failure: an animal study using a novel re-vascularized minimal human islet transplant model.
    Sahraoui A; Winzell MS; Gorman T; Smith DM; Skrtic S; Hoeyem M; Abadpour S; Johansson L; Korsgren O; Foss A; Scholz H
    PLoS One; 2015; 10(3):e0121204. PubMed ID: 25793295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo imaging of type 1 diabetes immunopathology using eye-transplanted islets in NOD mice.
    Abdulreda MH; Molano RD; Faleo G; Lopez-Cabezas M; Shishido A; Ulissi U; Fotino C; Hernandez LF; Tschiggfrie A; Aldrich VR; Tamayo-Garcia A; Bayer AS; Ricordi C; Caicedo A; Buchwald P; Pileggi A; Berggren PO
    Diabetologia; 2019 Jul; 62(7):1237-1250. PubMed ID: 31087105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperproliferative state of liver acini and pancreatic islets after intraportal transplantation of a small mass of islets of Langerhans in streptozotocininduced diabetic rats.
    Dombrowski F; Pfeifer U
    Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():112-17. PubMed ID: 8839266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice.
    Suarez-Pinzon WL; Power RF; Yan Y; Wasserfall C; Atkinson M; Rabinovitch A
    Diabetes; 2008 Dec; 57(12):3281-8. PubMed ID: 18835930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene transfer of constitutively active Akt markedly improves human islet transplant outcomes in diabetic severe combined immunodeficient mice.
    Rao P; Roccisana J; Takane KK; Bottino R; Zhao A; Trucco M; García-Ocaña A
    Diabetes; 2005 Jun; 54(6):1664-75. PubMed ID: 15919787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GABA promotes human β-cell proliferation and modulates glucose homeostasis.
    Purwana I; Zheng J; Li X; Deurloo M; Son DO; Zhang Z; Liang C; Shen E; Tadkase A; Feng ZP; Li Y; Hasilo C; Paraskevas S; Bortell R; Greiner DL; Atkinson M; Prud'homme GJ; Wang Q
    Diabetes; 2014 Dec; 63(12):4197-205. PubMed ID: 25008178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of prohormone convertase 2 promotes beta cell dysfunction in a rodent transplant model expressing human pro-islet amyloid polypeptide.
    Courtade JA; Wang EY; Yen P; Dai DL; Soukhatcheva G; Orban PC; Verchere CB
    Diabetologia; 2017 Mar; 60(3):453-463. PubMed ID: 27999871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets.
    Ludwig B; Ziegler CG; Schally AV; Richter C; Steffen A; Jabs N; Funk RH; Brendel MD; Block NL; Ehrhart-Bornstein M; Bornstein SR
    Proc Natl Acad Sci U S A; 2010 Jul; 107(28):12623-8. PubMed ID: 20616039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The novel anti-inflammatory agent lisofylline prevents autoimmune diabetic recurrence after islet transplantation.
    Yang Z; Chen M; Ellett JD; Fialkow LB; Carter JD; Nadler JL
    Transplantation; 2004 Jan; 77(1):55-60. PubMed ID: 14724435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disproportionate hyperproinsulinemia, beta-cell restricted prohormone convertase 2 deficiency, and cell cycle inhibitors expression by human islets transplanted into athymic nude mice: insights into nonimmune-mediated mechanisms of delayed islet graft failure.
    Davalli AM; Perego L; Bertuzzi F; Finzi G; La Rosa S; Blau A; Placidi C; Nano R; Gregorini L; Perego C; Capella C; Folli F
    Cell Transplant; 2008; 17(12):1323-36. PubMed ID: 19364070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival of an islet allograft deficient in iNOS after implantation into diabetic NOD mice.
    Börjesson A; Andersson AK; Sandler S
    Cell Transplant; 2006; 15(8-9):769-75. PubMed ID: 17269447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survey of the human pancreatic beta-cell G1/S proteome reveals a potential therapeutic role for cdk-6 and cyclin D1 in enhancing human beta-cell replication and function in vivo.
    Fiaschi-Taesch N; Bigatel TA; Sicari B; Takane KK; Salim F; Velazquez-Garcia S; Harb G; Selk K; Cozar-Castellano I; Stewart AF
    Diabetes; 2009 Apr; 58(4):882-93. PubMed ID: 19136653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocyte growth factor enhances engraftment and function of nonhuman primate islets.
    Fiaschi-Taesch NM; Berman DM; Sicari BM; Takane KK; Garcia-Ocaña A; Ricordi C; Kenyon NS; Stewart AF
    Diabetes; 2008 Oct; 57(10):2745-54. PubMed ID: 18820214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin gene transfer enhances the function of human islet grafts.
    Deng S; Vatamaniuk M; Lian MM; Doliba N; Wang J; Bell E; Wolf B; Raper S; Matschinsky FM; Markmann JF
    Diabetologia; 2003 Mar; 46(3):386-93. PubMed ID: 12687337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lixisenatide accelerates restoration of normoglycemia and improves human beta-cell function and survival in diabetic immunodeficient NOD-scid IL-2rg(null) RIP-DTR mice engrafted with human islets.
    Yang C; Loehn M; Jurczyk A; Przewozniak N; Leehy L; Herrera PL; Shultz LD; Greiner DL; Harlan DM; Bortell R
    Diabetes Metab Syndr Obes; 2015; 8():387-98. PubMed ID: 26316789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. XIAP gene expression protects β-cells and human islets from apoptotic cell death.
    Wu H; Panakanti R; Li F; Mahato RI
    Mol Pharm; 2010 Oct; 7(5):1655-66. PubMed ID: 20677802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.